--- title: "HLA Specific Antibody Detection & Identification System" ocid: "ocds-h6vhtk-0433b7" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0433b7" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-0433b7.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-0433b7.json" source: "Find A Tender Service" current_stage: "Planning" buyer: "NHS BLOOD AND TRANSPLANT" published: "2024-01-23" --- # HLA Specific Antibody Detection & Identification System Buyer: NHS BLOOD AND TRANSPLANT Current stage: Planning OCID: ocds-h6vhtk-0433b7 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0433b7) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-0433b7.json) ## Summary The NHS Blood and Transplant organization is planning a tender for the procurement of a Human Leukocyte Antigen (HLA) specific antibody detection and identification system. This tender falls under the medical equipment category with a total value of £8,000,000. The procurement process is in the planning stage, and interested parties must submit an expression of interest by 22/02/2024 to participate in remote supplier engagement meetings scheduled for 4th and 5th March 2024. This opportunity presents businesses in the medical equipment sector with a chance to provide HLA specific antibody detection systems to NHS Blood and Transplant. The procurement process is specifically looking for solutions that can detect and identify specific HLA antibodies efficiently and provide results within three hours. Organizations with expertise in medical equipment production and supply, particularly those familiar with HLA-specific technologies, are well-suited to compete in this tender for potential commercial contracts. ## Notice HLA specific antibody detection and definition system with Lot 1 and Lot 2 ### Lot Information Lot 1: Technical Requirements Section NHS Blood & Transplant (NHSBT) Histocompatibility & Immunogenetics function intends to undertake a tender exercise for Human Leukocyte Antigen (HLA) specific antibody detection and definition system(s) suitable for acute clinical work. Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHSBT, that provides a portfolio of testing, advice and support in transplantation, platelet refractoriness and transfusion reactions. Services are supplied through a national network of six laboratories across England. We would like to work with suppliers to perform HLA specific antibody detection and definition system in an efficient, timely and cost-effective manner to meet the demands and expectations of our customers and the patients we serve. Prior to commencing a formal procurement process and to help inform our strategy, NHSBT is seeking to engage with suppliers of commercially available HLA specific antibody detection and definition systems. Our current contract ends in February 2025 and NHSBT would like to improve our knowledge of all current and future systems available in the marketplace. This will aid identification of opportunities and gauge market interest in this field. We require HLA specific antibody detection and definition system to cover the following: * The solution must detect and identify specific HLA antibodies and detect IgG antibodies against all currently known HLA class I and Class II antigens (as detailed in the contemporaneous published HLA Dictionary. * The system must comprise of the essential equipment, analysis software and kit (s) to obtain a result and positive identification of samples throughout the process. * From test material addition to the availability of an interpreted results the turnaround time should be less than three hours. * Maintenance of existing equipment - Luminex (tm) detection systems. NB: Procurement of the above systems will be tendered by two lots. (Lot 1 new systems, lot 2 existing equipment) Respondents will be invited to pre-procurement engagement meetings on the 4th March and/or 5th March 2024 these will be held remotely. To enable NHSBT to finalise arrangements (e.g. send meeting details and agree time slots) for the supplier engagement meetings, interested organisations are required to send an expression of interest via email to coco.otiotio@nhsbt.nhs.uk by no later than 17:00 hrs (GMT) on 22/02/2024. This should include a list of your potential attendees and a brief overview (or a website link) of the Goods / Services which might be offered. Please include options, if available, to offer a managed service contract. No business whatsoever is guaranteed under any resulting framework agreement or contract, and there is no guarantee that any framework agreement or contract will be put in place in relation to this notice. No compensation etc. will be paid if a tender or resulting framework agreement is withdrawn for any reason. Bidders should take part in this process only on the basis that they fully understand and accept this position. It should be noted that this procurement exercise may allow other Health authorities to utilise any contracts/ framework agreements awarded. Lot 2: Technical Requirements Section NHS Blood & Transplant (NHSBT) Histocompatibility & Immunogenetics function intends to undertake a tender exercise for Human Leukocyte Antigen (HLA) specific antibody detection and definition system(s) suitable for acute clinical work. Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHSBT, that provides a portfolio of testing, advice and support in transplantation, platelet refractoriness and transfusion reactions. Services are supplied through a national network of six laboratories across England. We would like to work with suppliers to perform HLA specific antibody detection and definition system in an efficient, timely and cost-effective manner to meet the demands and expectations of our customers and the patients we serve. Prior to commencing a formal procurement process and to help inform our strategy, NHSBT is seeking to engage with suppliers of commercially available HLA specific antibody detection and definition systems. Our current contract ends in February 2025 and NHSBT would like to improve our knowledge of all current and future systems available in the marketplace. This will aid identification of opportunities and gauge market interest in this field. We require HLA specific antibody detection and definition system to cover the following: * The solution must detect and identify specific HLA antibodies and detect IgG antibodies against all currently known HLA class I and Class II antigens (as detailed in the contemporaneous published HLA Dictionary. * The system must comprise of the essential equipment, analysis software and kit (s) to obtain a result and positive identification of samples throughout the process. * From test material addition to the availability of an interpreted results the turnaround time should be less than three hours. * Maintenance of existing equipment - Luminex (tm) detection systems. NB: Procurement of the above systems will be tendered by two lots. (Lot 1 new systems, lot 2 existing equipment) Respondents will be invited to pre-procurement engagement meetings on the 4th March and/or 5th March 2024 these will be held remotely. To enable NHSBT to finalise arrangements (e.g. send meeting details and agree time slots) for the supplier engagement meetings, interested organisations are required to send an expression of interest via email to coco.otiotio@nhsbt.nhs.uk by no later than 17:00 hrs (GMT) on 22/02/2024. This should include a list of your potential attendees and a brief overview (or a website link) of the Goods / Services which might be offered. Please include options, if available, to offer a managed service contract. No business whatsoever is guaranteed under any resulting framework agreement or contract, and there is no guarantee that any framework agreement or contract will be put in place in relation to this notice. No compensation etc. will be paid if a tender or resulting framework agreement is withdrawn for any reason. Bidders should take part in this process only on the basis that they fully understand and accept this position. It should be noted that this procurement exercise may allow other Health authorities to utilise any contracts/ framework agreements awarded. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/002238-2024 | | Notice type | Planning Notice | | Procurement type | Standard | | Procurement category | Goods | | Procurement method | Not Specified | | Procurement method details | Not specified | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Planning | ## Dates | Field | Value | | --- | --- | | Publication date | 23 Jan 2024 | | Submission deadline | Not specified | | Future notice date | 23 Jan 2024 | | Award date | Not specified | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £8,000,000 | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Planned | | Lots status | Planned | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS BLOOD AND TRANSPLANT | | Locality | BRISTOL | | Post town | Bristol | | Postcode | BS16 7FG | | Country | England | | ITL 1 | TLK South West (England) | | ITL 2 | TLK5 West of England | | ITL 3 | TLK52 Bath & North East Somerset and South Gloucestershire | | Local authority | South Gloucestershire | | Electoral ward | Emersons Green | | Westminster constituency | Filton and Bradley Stoke | | Delivery location | Not specified | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33100000 - Medical equipments ## Release History - 23 Jan 2024 at 12:27 - Planning - Planning Notice - https://www.find-tender.service.gov.uk/Notice/002238-2024 ## Notice URLs - https://health-family.force.com/s/Welcome - https://www.nhsbt.nhs.uk ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0433b7. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-0433b7.json.